OXALION is a platinum-based cytotoxic drug that inhibits DNA synthesis in cancer cells. It is commonly administered as part of FOLFOX regimens.
Recommended for:
Colorectal cancer, gastric cancer, metastatic malignancies requiring systemic chemotherapy.
Administered intravenously as an infusion. Dosage is determined individually by a healthcare professional based on body surface area and chemotherapy protocol.
Contraindications:
Side Effects: